Northern Trust Corp Relmada Therapeutics, Inc. Transaction History

Northern Trust Corp

$658 Billion
Q1 2025

A detailed history of Northern Trust Corp transactions in Relmada Therapeutics, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 59,571 shares of RLMD stock, worth $32,764. This represents 0.0% of its overall portfolio holdings.

Number of Shares

59,571

Previous 84,282 29.32%

Holding current value

$32,764

Previous $43,000 62.79%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	SELL	$0.26 - $0.47 $6,424 - $11,614	-24,711 Reduced 29.32%	59,571 $16,000
Q4 2024 Feb 14, 2025	BUY	$0.35 - $3.65 $3,348 - $34,915	9,566 Added 12.8%	84,282 $43,000
Q3 2024 Nov 13, 2024	SELL	$2.3 - $4.36 $9,795 - $18,569	-4,259 Reduced 5.39%	74,716 $242,000
Q2 2024 Aug 14, 2024	SELL	$2.93 - $4.94 $6,076 - $10,245	-2,074 Reduced 2.56%	78,975 $236,000
Q1 2024 May 14, 2024	SELL	$3.1 - $6.8 $47,175 - $103,482	-15,218 Reduced 15.81%	81,049 $376,000
Q4 2023 Feb 13, 2024	BUY	$2.45 - $4.22 $120,454 - $207,476	49,165 Added 104.38%	96,267 $398,000
Q3 2023 Nov 13, 2023	SELL	$2.48 - $3.79 $863 - $1,318	-348 Reduced 0.73%	47,102 $141,000
Q2 2023 Aug 11, 2023	SELL	$2.22 - $3.54 $360,841 - $575,395	-162,541 Reduced 77.4%	47,450 $116,000
Q1 2023 May 15, 2023	SELL	$2.24 - $4.76 $41,121 - $87,384	-18,358 Reduced 8.04%	209,991 $474,000
Q4 2022 Feb 13, 2023	SELL	$2.17 - $35.84 $50,187 - $828,907	-23,128 Reduced 9.2%	228,349 $796,000
Q3 2022 Nov 14, 2022	BUY	$18.3 - $37.02 $25,729 - $52,050	1,406 Added 0.56%	251,477 $9.31 Million
Q2 2022 Aug 12, 2022	BUY	$16.5 - $30.34 $73,177 - $134,557	4,435 Added 1.81%	250,071 $4.75 Million
Q1 2022 May 13, 2022	BUY	$16.72 - $26.99 $1.2 Million - $1.94 Million	71,704 Added 41.23%	245,636 $6.63 Million
Q4 2021 Feb 08, 2022	BUY	$16.93 - $26.82 $181,608 - $287,698	10,727 Added 6.57%	173,932 $3.92 Million
Q3 2021 Nov 15, 2021	BUY	$21.86 - $34.77 $148,801 - $236,679	6,807 Added 4.35%	163,205 $4.28 Million
Q2 2021 Aug 13, 2021	SELL	$29.55 - $39.15 $186,046 - $246,488	-6,296 Reduced 3.87%	156,398 $5.01 Million
Q1 2021 May 12, 2021	SELL	$31.52 - $39.28 $323,836 - $403,562	-10,274 Reduced 5.94%	162,694 $5.73 Million
Q4 2020 Feb 11, 2021	SELL	$29.88 - $39.8 $121,014 - $161,190	-4,050 Reduced 2.29%	172,968 $5.55 Million
Q3 2020 Nov 16, 2020	SELL	$34.42 - $43.78 $182,598 - $232,252	-5,305 Reduced 2.91%	177,018 $6.66 Million
Q2 2020 Aug 14, 2020	BUY	$31.59 - $49.98 $4.92 Million - $7.78 Million	155,710 Added 585.09%	182,323 $8.16 Million
Q1 2020 May 14, 2020	BUY	$23.78 - $50.12 $55,454 - $116,879	2,332 Added 9.6%	26,613 $908,000
Q4 2019 Feb 14, 2020	BUY	$10.1 - $47.18 $245,238 - $1.15 Million	24,281 New	24,281 $947,000

Others Institutions Holding RLMD

# of Institutions

Shares Held

6.3M

Call Options Held

Put Options Held

View Full List

About RELMADA THERAPEUTICS, INC.

Ticker RLMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,608,500
Market Cap $15.7M
Description
Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that ...

More about RLMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Relmada Therapeutics, Inc. Transaction History